ArticleClinical and experimental medicine2023

Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis.

Bruna Cerbelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.